Group structure
3 companies in 1 country
United States1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELIGARD45 mg / syr · Powder For Suspension (Sustained-Release | Leuprorelin | Canada | Marketed | 2005 |
| ELIGARD22.5 mg / syr · Powder For Suspension (Sustained-Release | Leuprorelin | Canada | Marketed | 2003 |
| ELIGARD7.5 mg / syr · Powder For Suspension (Sustained-Release | Leuprorelin | Canada | Marketed | 2003 |
| ELIGARD30 mg / syr · Powder For Suspension (Sustained-Release | Leuprorelin | Canada | Marketed | 2004 |
| ELIGARD KIT22.5mg | 30mg | 45mg | 7.5mg · Powder | Leuprorelin | United States | Marketed | 2002 |
| FENSOLVI KIT45mg · Powder | Leuprorelin | United States | Marketed | 2020 |
| JATENZO237 mg · Capsule | Testosterone | Canada | Marketed | 2026 |
| JATENZO158mg | 198mg | 237mg · Capsule | Testosterone | United States | Marketed | 2019 |
| JATENZO158 mg · Capsule | Testosterone | Canada | Marketed | 2026 |
| JATENZO198 mg · Capsule | Testosterone | Canada | Marketed | 2026 |
| ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION | Leuprorelin | Saudi Arabia | Authorised | |
| ELIGARD 45 MG POWDER FOR SOLUTION FOR INJECTION | Leuprorelin | Saudi Arabia | Authorised | |
| ELIGARD 7.5 MG POWDER FOR SOLUTION FOR INJECTION | Leuprorelin | Saudi Arabia | Authorised | |
| PALIPERIDONE PALMITATE117mg/0.75ml | 156mg/ml | 234mg/1.5ml | 39mg/0.25ml | 78mg/0.5ml · Suspension, extended release | Paliperidone | United States | tentative | 2023 |